Rain Therapeutics Inc.
NASDAQ:RAIN
1.21 (USD) • At close January 25, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -7.034 | -22.064 | -20.484 | -22.678 | -18.041 | -17.611 | -17.394 | -17.985 | -18.426 | -8.183 | -6.8 | -5.443 | -10.447 | -2.624 | -2.569 |
| Depreciation & Amortization
| 0.154 | 0.017 | 0.018 | 0.018 | 0.018 | 0.022 | 0.022 | 0.021 | 0.021 | 0.014 | 0.015 | 0.012 | 0.013 | 0.012 | 0.015 |
| Deferred Income Tax
| 0.854 | 0.348 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 1.228 | 0.837 | 1.568 | 1.264 | 0.932 | 1.417 | 1.242 | 1.272 | 0.862 | 0.793 | 0.165 | 0.269 | 0.201 | 0.196 | 0.199 |
| Change In Working Capital
| -0.973 | -1.925 | -2.371 | 8.407 | 2.813 | -1.277 | -1.013 | 6.886 | 0.058 | -3.51 | 1.754 | 0.692 | 0.767 | 0.444 | -0.294 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 3.132 | -1.621 | 0.275 | 3.062 | 2.009 | -0.954 | -3.083 | 2.426 | -0.217 | 2.506 | 0.573 | -0.107 | 0.306 | 0.281 | 0.075 |
| Other Working Capital
| -4.105 | -0.304 | -2.646 | 5.345 | 0.804 | -0.323 | 2.07 | 4.46 | 0.275 | -6.016 | 1.181 | 0.799 | 0.461 | 0.163 | -0.369 |
| Other Non Cash Items
| -1.228 | -0.837 | -0.57 | -0.305 | -1.085 | 0.017 | 0.033 | 0.047 | 5.531 | 0.002 | 0 | 0.014 | 7.115 | 0.038 | 0.159 |
| Operating Cash Flow
| -6.999 | -23.624 | -21.839 | -13.294 | -15.363 | -17.432 | -17.11 | -9.759 | -11.954 | -10.884 | -4.866 | -4.456 | -2.351 | -1.934 | -2.49 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| -2.38 | -0 | 0 | -0.008 | 0 | 0 | 0 | 2.5 | -2.585 | -0.014 | -0.029 | -0.035 | -0.003 | 0 | 0 |
| Acquisitions Net
| 2 | 0 | 0 | 0.017 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -12.885 | -8.608 | -18.132 | -41.434 | -17.624 | -7.626 | -9.514 | -26.705 | -90.216 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 19.5 | 28.5 | 21.65 | 24.25 | 29.25 | 46.95 | 22.95 | 47.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -2 | -0.304 | 0 | -0.017 | 0 | 0 | 0 | -2.5 | 0 | -46.636 | 0 | 0 | -5.153 | 0 | 0 |
| Investing Cash Flow
| 4.235 | 19.588 | 3.518 | -17.192 | 11.626 | 39.324 | 13.436 | 21.245 | -92.801 | -46.65 | -0.029 | -0.035 | -5.156 | 0 | 0 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0.343 | 0 | 0 | 0 | 0 | 11.872 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0.212 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0.012 | -0.089 | 0.053 | 0 | 0 | 0 | -11.836 | 0 | 122.437 | -0.858 | -0.027 | 63.177 | 6.341 | 0 |
| Financing Cash Flow
| 0 | 0.012 | 0.466 | 0.053 | 0 | 0 | 0 | 0.036 | 0 | 122.437 | -0.858 | -0.027 | 63.177 | 6.341 | 0 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 4.861 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -2.764 | -4.024 | -17.855 | 22.121 | -3.575 | 21.904 | -3.275 | 11.522 | -104.755 | 64.903 | -5.753 | -4.518 | 55.67 | 4.407 | -2.49 |
| Cash At End Of Period
| 37.312 | 40.076 | 44.1 | 61.955 | 39.834 | 43.409 | 21.505 | 24.78 | 13.258 | 118.013 | 53.11 | 58.863 | 63.381 | 7.711 | 3.304 |